TMC Life Sciences (TMC) has appointed Wan Nadiah Wan Mohd Abdullah Yaakob (pictured) as its group chief corporate officer (COO). She will also assume the role of chief executive officer (CEO)-designate at Tropicana Medical Centre, a wholly owned subsidiary of TMC effective June 30.
Roy Quek, group CEO and executive director of TMC Life Sciences, said group COO is a newly created role and aside from looking after corporate matters as such human resources, marketing and communications, Abdullah Yaakob will also be assisting Quek in driving strategic planning in TMC.
Abdullah Yaakob replaces Erica Lam, who will return to the Parkway Pantai Group as CEO of Pantai Hospital Kuala Lumpur, according to Parkway Pantai Group’s spokesperson. Lam was Pantai Hospital Kuala Lumpur’s chief operating officer (COO) before she joined Tropicana Medical Centre as its COO in May 2011. She was promoted to the role of CEO at Tropicana Medical Centre in February 2012.
In a filing with Bursa Malaysia, TMC said prior to joining the group, Abdullah Yaakob was COO at Sunway Medical Centre, where she oversaw a full suite of clinical services and operations. She joined Sunway in 2009 and at one point, served as its director of business development and corporate communications.
Before joining Sunway, Abdullah Yaakob was an associate consultant at the Boston Consulting Group. Quek said Abdullah Yaakob joined the organisation as it enters an exciting period of expansion and growth.
We intend to build on this with our proposed expansion of Tropicana Medical Centre to a 600-bed tertiary care hospital and the proposed 500-bed Hospital Iskandariah in Johor Bahru.
“We will continue to build up our team as we grow and Abdullah Yaakob is a key member of our senior management team. I look forward to Abdullah Yaakob helping to drive TMC to even greater heights, starting with the ground-breaking for our new block at Tropicana Medical Centre,” he said.
TMC said it’s one of the fastest-growing private healthcare operators in Malaysia. Since 2011, the group has recorded compounded annual growth rate of 104% in profit after tax.
For the first six months of the current financial year, it has maintained its strong performance, managing year-to-date growth of 36% in profit after tax compared to the same period last year, according to TMC.